BIOGEN INC. Noncontrolling Interest, Increase from Business Combination
BIOGEN INC. (BIIB) reported Noncontrolling Interest, Increase from Business Combination of $2.00 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-23.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination · last filed 2019-02-06
- BIOGEN INC. noncontrolling interest, increase from business combination for the quarter ending 2018-09-30 was $2.00M.
- BIOGEN INC. noncontrolling interest, increase from business combination for the quarter ending 2018-06-30 was $11.10M.
- BIOGEN INC. noncontrolling interest, increase from business combination for the quarter ending 2017-09-30 was $0.00.
- BIOGEN INC. noncontrolling interest, increase from business combination for the quarter ending 2017-06-30 was $0.00.
- BIOGEN INC. noncontrolling interest, increase from business combination for fiscal 2016 was $600.00K, a 94.50% decline from fiscal 2015.
- BIOGEN INC. noncontrolling interest, increase from business combination for fiscal 2015 was $10.90M, a 62.69% increase from fiscal 2014.
- BIOGEN INC. noncontrolling interest, increase from business combination for fiscal 2014 was $6.70M.
| Period end | Noncontrolling Interest, Increase from Business Combination 3 month | Noncontrolling Interest, Increase from Business Combination 6 month | Noncontrolling Interest, Increase from Business Combination 9 month | Noncontrolling Interest, Increase from Business Combination 12 month | Noncontrolling Interest, Increase from Business Combination 12 month as first filed |
|---|---|---|---|---|---|
| 2018-09-30 | $2.00M 10-Q · filed 2018-10-23 | $13.10M derived: sum of 2 quarters · filed 2018-10-23 | $13.10M 10-Q · filed 2018-10-23 | ||
| 2018-06-30 | $11.10M 10-Q · filed 2018-07-24 | $11.10M 10-Q · filed 2018-07-24 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-10-23 | $0.00 derived: sum of 2 quarters · filed 2018-10-23 | $0.00 10-Q · filed 2018-10-23 | -$300.00K derived: sum of 4 quarters · filed 2019-02-06 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-07-24 | $0.00 10-Q · filed 2018-07-24 | -$300.00K derived: sum of 3 quarters · filed 2019-02-06 | -$300.00K derived: sum of 4 quarters · filed 2019-02-06 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-04-25 | -$300.00K derived: sum of 2 quarters · filed 2019-02-06 | -$300.00K derived: sum of 3 quarters · filed 2019-02-06 | -$300.00K derived: sum of 4 quarters · filed 2019-02-06 | |
| 2016-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$300.00K derived: sum of 2 quarters · filed 2019-02-06 | -$300.00K derived: sum of 3 quarters · filed 2019-02-06 | $600.00K 10-K · filed 2019-02-06 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-10-24 | $0.00 derived: sum of 2 quarters · filed 2017-10-24 | $900.00K 10-Q · filed 2017-10-24 | $11.70M derived: sum of 4 quarters · filed 2018-02-01 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-07-25 | $900.00K 10-Q · filed 2017-07-25 | $11.70M derived: sum of 3 quarters · filed 2018-02-01 | $11.90M derived: sum of 4 quarters · filed 2018-02-01 | |
| 2016-03-31 | $900.00K 10-Q · filed 2017-04-25 | $11.70M derived: sum of 2 quarters · filed 2018-02-01 | $11.90M derived: sum of 3 quarters · filed 2018-02-01 | $11.90M derived: sum of 4 quarters · filed 2018-02-01 | |
| 2015-12-31 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $11.00M derived: sum of 2 quarters · filed 2018-02-01 | $11.00M derived: sum of 3 quarters · filed 2018-02-01 | $10.90M 10-K · filed 2018-02-01 | |
| 2015-09-30 | $200.00K 10-Q · filed 2016-10-26 | $200.00K derived: sum of 2 quarters · filed 2016-10-26 | $100.00K 10-Q · filed 2016-10-26 | $2.90M derived: sum of 4 quarters · filed 2016-10-26 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-07-21 | $0.00 10-Q · filed 2016-07-21 | $2.70M derived: sum of 3 quarters · filed 2016-07-21 | $2.70M derived: sum of 4 quarters · filed 2016-07-21 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-04-21 | $2.70M derived: sum of 2 quarters · filed 2016-04-21 | $2.70M derived: sum of 3 quarters · filed 2016-04-21 | $2.70M derived: sum of 4 quarters · filed 2016-04-21 | |
| 2014-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $2.70M derived: sum of 2 quarters · filed 2016-02-03 | $2.70M derived: sum of 3 quarters · filed 2016-02-03 | $6.70M 10-K · filed 2016-02-03 | $6.70M 10-K · filed 2015-02-04 |
| 2014-09-30 | $0.00 10-Q · filed 2015-10-21 | $0.00 derived: sum of 2 quarters · filed 2015-10-21 | $4.00M 10-Q · filed 2015-10-21 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-07-24 | $4.00M 10-Q · filed 2015-07-24 | |||
| 2014-03-31 | $4.00M 10-Q · filed 2015-04-24 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-10-22 | $0.00 derived: sum of 2 quarters · filed 2014-10-22 | $0.00 10-Q · filed 2014-10-22 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-07-23 | $0.00 10-Q · filed 2014-07-23 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |